Search for: "WYETH PHARMACEUTICALS COMPANY"
Results 381 - 400
of 547
Sorted by Relevance
|
Sort by Date
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb)… [read post]
3 Jan 2012, 10:20 am
Wyeth LLC, 131 S. [read post]
18 Oct 2010, 12:05 pm
Novartis Pharmaceuticals Corp., MID-L-1835-08-MT, Middlesex County. [read post]
12 May 2008, 2:46 pm
For reasons I have written about previously, I believe that patients should not be pre-empted, or prohibited, from filing lawsuits against medical device and pharmaceutical companies. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360)… [read post]
15 Oct 2008, 3:02 pm
The Supreme Court wil shortly hear these arguments in the context of a drug case and FDA preamble that attempts to grant immunity, when Wyeth v. [read post]
18 Jan 2007, 7:53 pm
Wyeth-Ayerst Labs., 82 S.W.3d 849, 857 (Ky. 2002); Hinton v. [read post]
27 May 2010, 3:20 am
(Patent Docs) Restoril (Temazepam) – US: District Court New Jersey: Covidien’s patent for Restoril found obvious: Tyco Healthcare v Mutual Pharmaceutical Company (Patent Docs) Seroquel (Quetiapine) – US: Patent infringement complaint following Paragraph IV challenge: AstraZeneca Pharmaceuticals LP et al. v. [read post]
8 Jul 2009, 7:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Humira (Adalimumab) – US: Largest patent verdict in history – Abbott to pay $1.67 billion to Centocor because Humira found to… [read post]
7 Jan 2011, 11:41 am
The rationale behind passage of the Act was the fear that pharmaceutical companies would stop manufacturing vaccines if they were exposed to litigation for defective vaccines. [read post]
7 Jan 2011, 11:41 am
The rationale behind passage of the Act was the fear that pharmaceutical companies would stop manufacturing vaccines if they were exposed to litigation for defective vaccines. [read post]
2 Jun 2011, 12:46 pm
Wyeth Inc., 488 F. [read post]
22 Feb 2008, 1:30 pm
Nonetheless, the administration is arguing in the case the court has accepted for its next term, Wyeth v. [read post]
30 Dec 2013, 5:25 am
Wyeth Pharmaceuticals, ___ F.3d ___, 2013 WL 6224337 (6th Cir. [read post]
10 Oct 2008, 11:32 am
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) - US: Trial judge grants permanent injunction in case relating to recombinant erythropoietin (EPO) patent: Amgen v… [read post]
24 Jan 2008, 12:25 pm
The Wyeth v. [read post]
23 Jul 2007, 6:58 am
It was what attorney Robert Brava-Partain, the ubiquitous suer of pharmaceutical companies, had to say. [read post]
30 Mar 2016, 8:00 am
Supreme Court decision in Wyeth v. [read post]
31 Jan 2009, 6:50 am
The rule discourages medical device manufactures and pharmaceutical companies from updating warning labels with hazard information without prior FDA approval, a blatant attempt to influence the Supreme Court’s decision in Wyeth v. [read post]
2 Nov 2008, 4:00 am
Levine (06-1249), on whether pharmaceutical companies can be sued under state law for ineffective drug labels the FDA had previously approved. [read post]
